Evidence map›Paper›PMID 12196556›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2002

No ligand binding in the GB2 subunit of the GABA(B) receptor is required for activation and allosteric interaction between the subunits.

Julie Kniazeff, Thierry Galvez, Gilles Labesse, Jean-Philippe Pin

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
4.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 151 citations in OpenAlex.

  1. GABA-independent activation of GABANature communications · 2025
    Article
  2. Review
  3. Review
  4. GABACurrent topics in behavioral neurosciences · 2022
    Article
  5. GABACurrent topics in behavioral neurosciences · 2022
    Review
  6. Review
  7. Review
  8. Ectopic activation of GABANature ecology & evolution · 2021
    Article
  9. The GABAMolecules (Basel, Switzerland) · 2020
    Review
  10. Exploring Conformational Dynamics of the ExtracellularJournal of chemical information and modeling · 2020
    Article
  11. In Silico Methods for the Discovery of Orthosteric GABAMolecules (Basel, Switzerland) · 2019
    Article
  12. Structural biology of GABANeuropharmacology · 2018
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. GABA Receptors Genes Polymorphisms and Alcohol Dependence: No Evidence of an Association in an Italian Male Population.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Julie KniazeffCentre National de la Recherche Scientifique-Unité Propre de Recherche 9023, Mécanismes Moléculaires des Communications Cellulaires, 34094 Montpellier Cedex 5, France.
Thierry Galvez
Gilles Labesse
Jean-Philippe Pin
Centre National de la Recherche Scientifique · FRCentre de Biologie Structurale · FR

Funding

Detection/Dysplastic Epithelium/Gastrointestinal TractR33CA094304 · NCI · UNIVERSITY HOSPITALS OF CLEVELAND · PI SIVAK, MICHAEL V · 2002 to 2004
$1.5M
NCI NIH HHS R33 CA094304
6 · The paper itself

Abstract

The GABA(B) receptor plays important roles in the tuning of many synapses. Although pharmacological differences have been observed between various GABA(B)-mediated effects, a single GABA(B) receptor composed of two subunits (GB1 and GB2) has been identified. Although GB1 binds GABA, GB2 plays a critical role in G-protein activation. Moreover, GB2 is required for the high agonist affinity of GB1. Like any other family 3 G-protein-coupled receptors, GB1 and GB2 are composed of a Venus Flytrap module (VFTM) that usually contains the agonist-binding site and a heptahelical domain. So far, there has been no direct demonstration that GB2 binds GABA or another endogenous ligand. Here, we have further refined the GABA-binding site of GB1 and characterized the putative-binding site in the VFTM of GB2. None of the residues important for GABA binding in GB1 appeared to be conserved in GB2. Moreover, mutation of 10 different residues, alone or in combination, within the possible binding pocket of GB2 affects neither GABA activation of the receptor nor the ability of GB2 to increase agonist affinity on GB1. These data indicate that ligand binding in the GB2 VFTM is not required for activation. Finally, although in either GB1 or the related metabotropic glutamate receptors most residues of the binding pocket are conserved from Caenorhabditis elegans to human, no such conservation is observed in GB2. This suggests that the GB2 VFTM does not constitute a binding site for a natural ligand.

Indexed as

Protein SubunitsAllosteric RegulationAnimalsBinding, CompetitiveBinding SitesCaenorhabditis elegansCell LineDimerizationDrosophila melanogasterEvolution, Moleculargamma-Aminobutyric AcidHumansImaging, Three-DimensionalKidneyLigandsMicegamma-Aminobutyric AcidLigandsProtein SubunitsReceptors, GABA-B

Identifiers

PMID12196556
PMCPMC6757956
OpenAlexW2128780400

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.